Dabek Robert J, Bizanti Anas, Thomas Samantha, Kalla Abhishek, Hamdallah Isam
Department of Surgery, Saint Agnes Hospital, Baltimore, USA.
Department of Internal Medicine, Saint Agnes Hospital, Baltimore, USA.
Cureus. 2020 Sep 30;12(9):e10739. doi: 10.7759/cureus.10739.
Metastasis of extra-intestinal carcinoma to the gastrointestinal tract (GIT) is a rare event, most commonly occurring with malignant melanoma. Anti-PD-1 (programmed death-1) immunotherapeutic agents are immune checkpoint inhibitors with proven benefit across multiple cancer types, including squamous cell carcinoma of the head and neck (SCCHN). Here we describe a case of small bowel perforation attributed to a primary SCCHN metastasizing to the GIT in the setting of treatment with PD-1 inhibitors.
肠外癌转移至胃肠道(GIT)是一种罕见事件,最常见于恶性黑色素瘤。抗程序性死亡蛋白1(PD-1)免疫治疗药物是免疫检查点抑制剂,已被证明对多种癌症类型有效,包括头颈部鳞状细胞癌(SCCHN)。在此,我们描述了一例在接受PD-1抑制剂治疗期间,原发性SCCHN转移至GIT导致小肠穿孔的病例。